According to ANI Pharmaceuticals's latest financial reports the company's total liabilities are โฌ0.79 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | โฌ0.82 B | 103.31% |
2023-12-31 | โฌ0.40 B | 2.85% |
2022-12-31 | โฌ0.39 B | 7.8% |
2021-12-31 | โฌ0.36 B | 68.89% |
2020-12-31 | โฌ0.21 B | -0.9% |
2019-12-31 | โฌ0.21 B | 6.79% |
2018-12-31 | โฌ0.20 B | 3.1% |
2017-12-31 | โฌ0.19 B | 35.82% |
2016-12-31 | โฌ0.14 B | 27.23% |
2015-12-31 | โฌ0.11 B | 16.26% |
2014-12-31 | โฌ98.48 M | 3744.06% |
2013-12-31 | โฌ2.56 M | -68.01% |
2012-12-31 | โฌ8 M | -57.66% |
2011-12-31 | โฌ18.91 M | -1.79% |
2010-12-31 | โฌ19.26 M | 33.92% |
2009-12-31 | โฌ14.38 M | 421.87% |
2008-12-31 | โฌ2.75 M | 165.47% |
2007-12-31 | โฌ1.03 M | -68.14% |
2006-12-31 | โฌ3.25 M | 40.07% |
2005-12-31 | โฌ2.32 M | 65.5% |
2004-12-31 | โฌ1.4 M | 100.83% |
2003-12-31 | โฌ0.69 M | -41.76% |
2002-12-31 | โฌ1.2 M | 14.39% |
2001-12-31 | โฌ1.05 M |